• Product NameBenazepril hydrochloride
• Brief DescriptionInhibitors
• Purification99.50%
• Biological ActivityBenazepril, brand name Lotensin, is a medication used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure. Upon cleavage of its ester group by the liver, benazepril is converted into its active form benazeprilat, a non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor.
• Target NameRAAS inhibitor
• CAS No. 86541-74-4
• Calculated MW 460.95
• Formulation C24H29ClN2O5
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cardiovascular System
  SMILES:CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O.Cl
  Pathways:Endocrinology/Hormones
  Receptor:ACE
  Boling pt:691.2C
  Melting pt:188-190C
  Solubility:Ethanol: 92 mg/mL (199.58 mM); Water: 19 mg/mL (41.21 mM); DMSO: 92 mg/mL (199.58 mM)
  Appearance:White Crystal
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Song JC, White CM. Clin Pharmacokinet. 2002;41(3):207-24.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting